Univerzitetni klinični center Maribor (SBMB)
  • Treatment of chronic hepatitis C : our experience
    Brinovec, Vladimir ...
    Background/Aims: While an optimal treatment of chronic hepatitis C has not yet been established, it has been demonstrated that the interferon a/ribavirin combination is more effective than interferon ... a monotherapy. Methodology: One hundred and forty-three patients with chronic hepatitis C received the following treatment: eighty patients an 18-month monotherapy (3-month follow-up) and sixty-three patients a 12-month combined therapy (6-month follow-up). Therapeutic efficacy and adverse effects were compared. Results: In 80 patients in the monotherapy group, complete response was achieved in 49.2 %. This was reduced to 27.5 % three months after therapy. Significant differences were observed in HCV 3 genotype where complete response was achieved in 12 out of 14 patients (p=0.01). With the combined therapy administered to 63 patients, complete response was achieved in 54.5 %.This was reduced to 43.2 % after 6 months of follow-up. Among the responders or partial responders, significant differences were observed with regard to age (p=0.0047) and subtype 1b (p=0.012). Comparing the groups of naive patients and relapsers, a statistically significant difference (p=0.027) was found in therapeutic efficacy. Conclusions: In the treatment of chronic hepatitis C, combined therapy proved more effective than monotherapy. This is, however, not yet a sar=tisfactory solution.
    Vir: Hepato-gastroenterology. - ISSN 0172-6390 (Vol. 51, 2004, str. 506-511)
    Vrsta gradiva - članek, sestavni del ; neleposlovje za odrasle
    Leto - 2004
    Jezik - angleški
    COBISS.SI-ID - 1440063

vir: Hepato-gastroenterology. - ISSN 0172-6390 (Vol. 51, 2004, str. 506-511)

loading ...
loading ...
loading ...